Viewing Study NCT04806035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2026-02-10 @ 2:32 PM
Study NCT ID: NCT04806035
Status: TERMINATED
Last Update Posted: 2024-07-31
First Post: 2021-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
Sponsor: TG Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CLL View
None SLL View
None Richter's Transformation View
None Indolent Lymphoma View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
None Aggressive Lymphoma View
None DLBCL View
None Mediastinal Large B-cell Lymphoma View
None MCL View
Keywords: